首页 > 最新文献

Vasa-european Journal of Vascular Medicine最新文献

英文 中文
BEST-CLI and BASIL-2 - and now? BEST-CLI 和 BASIL-2 - 现在呢?
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1024/0301-1526/a001108
Tanja Böhme
{"title":"BEST-CLI and BASIL-2 - and now?","authors":"Tanja Böhme","doi":"10.1024/0301-1526/a001108","DOIUrl":"10.1024/0301-1526/a001108","url":null,"abstract":"","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis. 深静脉血栓形成中的凝血监测、剂量调整导管导向溶栓或药物机械血栓清除。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-17 DOI: 10.1024/0301-1526/a001097
Julian Kleine Wortmann, Stefano Barco, Riccardo M Fumagalli, Davide Voci, Ulrike Hügel, Rahel Cola, David Spirk, Nils Kucher, Tim Sebastian

Background: Pharmaco-mechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) are therapeutic options for selected patients with acute deep vein thrombosis (DVT) to prevent post-thrombotic syndrome (PTS). Patients and methods: We aimed to describe the clinical characteristics and outcomes of 159 patients with symptomatic iliofemoral DVT undergoing PMT alone, CDT alone, or CDT followed by PMT (bail-out) in the Swiss Venous Stent Registry. The primary outcome was the incidence of peri-interventional major and minor bleeding complications (ISTH criteria). Secondary outcomes included the incidence of PTS and stent patency after 3 years. Results: Mean age was 49±20 years and 58% were women. DVT involved the iliac veins in 99% of patients, whereas 53% had an underlying iliac vein compression. PMT alone was used in 40 patients, CDT alone in 77, and 42 received initial CDT followed by bail-out PMT due to insufficient thrombus clearance. Single-session PMT was the preferred approach in patients with iliac vein compression, patent popliteal vein, and absence of IVC thrombus. Patients treated with PMT alone received a lower r-tPA dose (median 10 mg, IQR 10-10) vs. those treated with CDT (20 mg, IQR 10-30). The rate of peri-interventional major bleeding was 0%, 1%, and 2%, whereas that of minor bleeding was 0%, 1%, and 12%, respectively, all occurring during CDT. After 3 years, PTS occurred in 6%, 9%, and 7% of patients, respectively. The primary stent patency rate was 95%, 88%, and 83%, respectively. Conclusions: The use of PMT and CDT for iliofemoral DVT was overall safe and resulted in high long-term patency and treatment success. Given the less severe presentation of DVT, single-session PMT appeared to be characterized by numerically better primary patency and lower perioperative bleeding event rates than CDT.

背景:药物机械血栓切除术(PMT)和导管导向溶栓(CDT)是选定的急性深静脉血栓形成(DVT)患者预防血栓形成后综合征(PTS)的治疗选择。患者和方法:我们旨在描述159名有症状的髂股深静脉血栓形成患者的临床特征和结果,这些患者在瑞士静脉支架登记处接受单独PMT、单独CDT或CDT后再行PMT(纾困)。主要结果是介入治疗前后大出血和小出血并发症的发生率(ISTH标准)。次要结果包括PTS的发生率和3年后支架通畅率。结果:平均年龄49±20岁,女性占58%。99%的患者DVT涉及髂静脉,而53%的患者有潜在的髂静脉压迫。40名患者单独使用PMT,77名患者单独服用CDT,42名患者因血栓清除不足接受了初次CDT,随后接受了PMT。对于髂静脉压迫、腘静脉未闭和无IVC血栓的患者,单次PMT是首选方法。单独接受PMT治疗的患者接受的r-tPA剂量(中位数为10 mg,IQR 10-10)低于接受CDT治疗的患者(20 mg,IQR10-30)。介入期大出血发生率分别为0%、1%和2%,而小出血发生率则分别为0%,1%和12%,均发生在CDT期间。3年后,PTS发生率分别为6%、9%和7%。主要支架通畅率分别为95%、88%和83%。结论:应用PMT和CDT治疗髂股深静脉血栓形成总体安全,远期通畅率高,治疗成功率高。鉴于DVT的表现不那么严重,单次PMT的特点似乎是在数量上比CDT更好的初次通畅性和更低的围手术期出血事件率。
{"title":"Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis.","authors":"Julian Kleine Wortmann, Stefano Barco, Riccardo M Fumagalli, Davide Voci, Ulrike Hügel, Rahel Cola, David Spirk, Nils Kucher, Tim Sebastian","doi":"10.1024/0301-1526/a001097","DOIUrl":"10.1024/0301-1526/a001097","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Pharmaco-mechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) are therapeutic options for selected patients with acute deep vein thrombosis (DVT) to prevent post-thrombotic syndrome (PTS). <i>Patients and methods:</i> We aimed to describe the clinical characteristics and outcomes of 159 patients with symptomatic iliofemoral DVT undergoing PMT alone, CDT alone, or CDT followed by PMT (bail-out) in the Swiss Venous Stent Registry. The primary outcome was the incidence of peri-interventional major and minor bleeding complications (ISTH criteria). Secondary outcomes included the incidence of PTS and stent patency after 3 years. <i>Results:</i> Mean age was 49±20 years and 58% were women. DVT involved the iliac veins in 99% of patients, whereas 53% had an underlying iliac vein compression. PMT alone was used in 40 patients, CDT alone in 77, and 42 received initial CDT followed by bail-out PMT due to insufficient thrombus clearance. Single-session PMT was the preferred approach in patients with iliac vein compression, patent popliteal vein, and absence of IVC thrombus. Patients treated with PMT alone received a lower r-tPA dose (median 10 mg, IQR 10-10) vs. those treated with CDT (20 mg, IQR 10-30). The rate of peri-interventional major bleeding was 0%, 1%, and 2%, whereas that of minor bleeding was 0%, 1%, and 12%, respectively, all occurring during CDT. After 3 years, PTS occurred in 6%, 9%, and 7% of patients, respectively. The primary stent patency rate was 95%, 88%, and 83%, respectively. <i>Conclusions:</i> The use of PMT and CDT for iliofemoral DVT was overall safe and resulted in high long-term patency and treatment success. Given the less severe presentation of DVT, single-session PMT appeared to be characterized by numerically better primary patency and lower perioperative bleeding event rates than CDT.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of manual lymphatic drainage and intermittent pneumatic compression in lymphedema maintenance therapy. 手动淋巴引流和间歇气压加压在淋巴水肿维持治疗中的疗效。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-16 DOI: 10.1024/0301-1526/a001090
Erika Mendoza, Felix Amsler

Background: To compare the effectiveness of intermittent pneumatic compression (IPC) and/or manual lymphatic drainage (MLD) associated to compression stockings in the maintenance treatment of lymphedema. Patients and methods: Patients in the maintenance phase of lymphedema therapy with MLD and compression since more than a year with stable values for weight and circumferences of ankle and calf were asked to participate in a study: Compression had to be worn daily, (1) 4 weeks IPC+MLD, (2) 4 weeks MLD alone, (3) 4 Weeks IPC alone (Order 1 and 3 was randomized). At the beginning and after each 4 weeks, circumference measurements (by hand and by machine: BT600®, Bauerfeind) were documented, pain and discomfort were assessed, and quality-of-life questionnaires were completed. Results: Of 20 participants, 18 (14 female, 4 male), mean age 59.6 years (48-89) could be evaluated. 11 subjects had bilateral, 7 unilateral, 5 primary, 13 secondary lymphedema since 2-20 years (mean 7.7), the subjects had received MLD and compression for 2-14 years (mean 6.4), 1-3 times per week (mean 1.5). The BMI ranged between 21 and 47 (mean 33.7). No differences between any phases were found for: Calf and thigh volume, circumference of calf. Only the ankle circumference was significant less (-0.22 cm) when using "both" (IPC+MLD). Compared to before the study, quality of life was better in all three phases, but with a significantly higher improvement in the phases with IPC than in the phases without. Conclusions: There were no differences in objective measurement between MLD alone, IPC alone or both, excepting the minimal significant difference in ankle circumference after IPC+MLD. QOL favored IPC application. Considering the economic consequences of these results, a change of maintenance therapy with MLD weekly over years in favor of permanent care with IPC and few appointments of MLD per year should be considered and further investigated.

背景:比较间歇性气动压迫(IPC)和/或手动淋巴引流(MLD)联合压迫袜维持治疗淋巴水肿的有效性。患者和方法:自一年多以来,处于MLD和压迫淋巴水肿治疗维持阶段的患者,其脚踝和小腿的重量和周长值稳定,被要求参与一项研究:压迫必须每天佩戴,(1)4周IPC+MLD,(2)4周MLD单独,(3)4周工控单独(顺序1和3随机)。在开始时和每4周后,记录周长测量(手动和机器测量:BT600®,Bauerfeind),评估疼痛和不适,并完成生活质量问卷。结果:在20名参与者中,可以评估18名(14名女性,4名男性),平均年龄59.6岁(48-89岁)。自2-20年以来,11名受试者出现双侧淋巴水肿,7名单侧淋巴水肿,5名原发性淋巴水肿,13名继发性淋巴水肿(平均7.7),受试者接受MLD和压迫2-14年(平均6.4),每周1-3次(平均1.5)。BMI在21-47之间(平均33.7)。小腿和大腿体积、小腿周长在任何阶段都没有差异。当使用“两者”(IPC+MLD)时,只有脚踝周长显著小于(-0.22厘米)。与研究前相比,所有三个阶段的生活质量都更好,但有IPC的阶段的改善明显高于没有IPC的阶段。结论:单用MLD、单用IPC或两者在客观测量方面没有差异,除了IPC+MLD后脚踝周长的差异最小。QOL青睐IPC应用。考虑到这些结果的经济后果,应考虑并进一步调查多年来每周MLD维持治疗的变化,以支持IPC的永久性护理,以及每年很少预约MLD。
{"title":"Effectiveness of manual lymphatic drainage and intermittent pneumatic compression in lymphedema maintenance therapy.","authors":"Erika Mendoza, Felix Amsler","doi":"10.1024/0301-1526/a001090","DOIUrl":"10.1024/0301-1526/a001090","url":null,"abstract":"<p><p><b></b> <i>Background:</i> To compare the effectiveness of intermittent pneumatic compression (IPC) and/or manual lymphatic drainage (MLD) associated to compression stockings in the maintenance treatment of lymphedema. <i>Patients and methods:</i> Patients in the maintenance phase of lymphedema therapy with MLD and compression since more than a year with stable values for weight and circumferences of ankle and calf were asked to participate in a study: Compression had to be worn daily, (1) 4 weeks IPC+MLD, (2) 4 weeks MLD alone, (3) 4 Weeks IPC alone (Order 1 and 3 was randomized). At the beginning and after each 4 weeks, circumference measurements (by hand and by machine: BT600<sup>®</sup>, Bauerfeind) were documented, pain and discomfort were assessed, and quality-of-life questionnaires were completed. <i>Results:</i> Of 20 participants, 18 (14 female, 4 male), mean age 59.6 years (48-89) could be evaluated. 11 subjects had bilateral, 7 unilateral, 5 primary, 13 secondary lymphedema since 2-20 years (mean 7.7), the subjects had received MLD and compression for 2-14 years (mean 6.4), 1-3 times per week (mean 1.5). The BMI ranged between 21 and 47 (mean 33.7). No differences between any phases were found for: Calf and thigh volume, circumference of calf. Only the ankle circumference was significant less (-0.22 cm) when using \"both\" (IPC+MLD). Compared to before the study, quality of life was better in all three phases, but with a significantly higher improvement in the phases with IPC than in the phases without. <i>Conclusions:</i> There were no differences in objective measurement between MLD alone, IPC alone or both, excepting the minimal significant difference in ankle circumference after IPC+MLD. QOL favored IPC application. Considering the economic consequences of these results, a change of maintenance therapy with MLD weekly over years in favor of permanent care with IPC and few appointments of MLD per year should be considered and further investigated.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of endovascular treatment for popliteal artery disease. 腘动脉疾病血管内治疗的结果。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-16 DOI: 10.1024/0301-1526/a001096
Arne M Müller, Leoni Löhn-Kannengießer, Christian Bradaric, Ralf Dirschinger, Tobias Koppara, Katharina Bergmann, Victoria Kehl, Salvatore Cassese, Erion Xhepa, Adnan Kastrati, Karl-Ludwig Laugwitz, Tareq Ibrahim

Background: Finding the appropriate endovascular revascularization strategy for patients with peripheral artery disease and a popliteal artery lesion remains particulary challenging. Data regarding predictors for a beneficial outcome are scarce. Patients and methods: All endovascular procedures of popliteal artery lesions (n=227) performed in 197 patients between February 2009 and May 2018 at our institution were retrospectively analyzed. Hemodynamically relevant restenosis represented the primary endpoint. Results: The overall technical success rate was 98% and yielded 99% for stenoses (n=145) and 97% for occlusions (n=82). In a median follow-up of 10 months, the overall rate of restenosis was 23%. After 1 and 2 years, the primary patency rates were 76% and 55% and the secondary patency rate was 100%, respectively. The estimated probability of restenosis was significantly higher in stented lesions (stent vs. no stent; 36.0% vs. 19.1%; p=0.030). Multivariate analysis identified stent implantation (hazard ratio: 2.4; overall P=0.010) and diabetes (hazard ratio 2.0; P=0.023) as significant predictors for the development of restenosis. Conclusions: Endovascular therapy for popliteal artery disease was associated with high technical success rates and accompanied with a promising mid-term outcome, particularly in lesions treated with balloon angioplasty alone.

背景:为外周动脉疾病和腘动脉病变患者寻找合适的血管内血运重建策略仍然具有特别的挑战性。关于有益结果的预测因素的数据很少。患者和方法:回顾性分析2009年2月至2018年5月在我们机构对197名患者进行的腘动脉病变(n=227)的所有血管内手术。血液动力学相关的再狭窄是主要终点。结果:总的技术成功率为98%,狭窄(n=145)和闭塞(n=82)分别为99%和97%。在10个月的中位随访中,再狭窄的总发生率为23%。1年和2年后,一期通畅率分别为76%和55%,二期通畅率为100%。支架病变发生再狭窄的估计概率明显更高(支架与无支架相比;36.0%与19.1%;p=0.030)。多因素分析确定支架植入(危险比:2.4;总体p=0.010)和糖尿病(危险比2.0;p=0.023)是再狭窄发展的重要预测因素。结论:腘动脉疾病的血管内治疗具有较高的技术成功率,并伴有有希望的中期结果,特别是在仅用球囊血管成形术治疗的病变中。
{"title":"Outcomes of endovascular treatment for popliteal artery disease.","authors":"Arne M Müller, Leoni Löhn-Kannengießer, Christian Bradaric, Ralf Dirschinger, Tobias Koppara, Katharina Bergmann, Victoria Kehl, Salvatore Cassese, Erion Xhepa, Adnan Kastrati, Karl-Ludwig Laugwitz, Tareq Ibrahim","doi":"10.1024/0301-1526/a001096","DOIUrl":"10.1024/0301-1526/a001096","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Finding the appropriate endovascular revascularization strategy for patients with peripheral artery disease and a popliteal artery lesion remains particulary challenging. Data regarding predictors for a beneficial outcome are scarce. <i>Patients and methods:</i> All endovascular procedures of popliteal artery lesions (n=227) performed in 197 patients between February 2009 and May 2018 at our institution were retrospectively analyzed. Hemodynamically relevant restenosis represented the primary endpoint. <i>Results:</i> The overall technical success rate was 98% and yielded 99% for stenoses (n=145) and 97% for occlusions (n=82). In a median follow-up of 10 months, the overall rate of restenosis was 23%. After 1 and 2 years, the primary patency rates were 76% and 55% and the secondary patency rate was 100%, respectively. The estimated probability of restenosis was significantly higher in stented lesions (stent vs. no stent; 36.0% vs. 19.1%; p=0.030). Multivariate analysis identified stent implantation (hazard ratio: 2.4; overall P=0.010) and diabetes (hazard ratio 2.0; P=0.023) as significant predictors for the development of restenosis. <i>Conclusions:</i> Endovascular therapy for popliteal artery disease was associated with high technical success rates and accompanied with a promising mid-term outcome, particularly in lesions treated with balloon angioplasty alone.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review of endovenous ablation for the treatment of small saphenous varicose veins. 静脉内消融术治疗小隐静脉曲张的系统综述。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-02 DOI: 10.1024/0301-1526/a001091
Junjie Tan, Yanhui Chen, Jianwen Huang, Weiguo Xu

Insufficiency of the small saphenous vein causes 15% of varicose veins in the lower extremities. Endovenous ablation for the treatment of small saphenous vein varices has become a trend, and an increasing number of studies have reported the effects of different types of endovenous ablation in patients with small saphenous varicose veins. The purpose of this systematic review is to summarize the results of existing studies on endovenous ablation for the treatment of small saphenous varicose veins, compare its role and efficacy, and provide insights into the future development of endovenous ablation for treating small saphenous varicose veins. A systematic review of literature published from January 1, 2002 to January 1, 2022 was conducted from PubMed, Embase, and China Academic Journals full-text databases. The pre-determined inclusion criteria were clinical literature of endovenous ablation for treating small saphenous varicose veins. Keywords included "ablation", "small saphenous vein", "lesser saphenous vein", "short saphenous vein", "xiaoyinjingmai" and "xiaorong". Of the 506 articles screened, 33 articles were included in this review: 19 articles were related to endovenous laser ablation, five were related to mechanochemical ablation, seven were related to radiofrequency ablation, and two were related to both endovenous laser ablation and radiofrequency ablation. The anatomical success rate of endovenous laser ablation, radiofrequency ablation, and mechanochemical ablation were 94.3%, 96.0%, and 88.1%, respectively, and the heterogeneities were all moderate. Most of the current studies are of a low-quality level of research. Hence, long-term follow-up studies and large-scale randomized controlled trials are required to obtain high-quality evidence. Although the gold standard for the treatment of small saphenous vein insufficiency remains unclear, endovenous ablation is still the recommended method.

小隐静脉功能不全导致15%的下肢静脉曲张。静脉内消融术治疗小隐静脉曲张已成为一种趋势,越来越多的研究报道了不同类型的静脉内消蚀术对小隐静脉静脉曲张患者的影响。本系统综述的目的是总结静脉内消融术治疗小隐静脉曲张的现有研究结果,比较其作用和疗效,并对静脉内消蚀术治疗小静脉曲张的未来发展提供见解。从PubMed、Embase和中国学术期刊全文数据库对2002年1月1日至2022年1月31日发表的文献进行了系统综述。预先确定的纳入标准是静脉内消融术治疗小隐静脉曲张的临床文献。关键词包括“消融术”、“小隐静脉”、“小隐静脉”和“短隐静脉”,“消隐精脉”和“消荣”。在筛选的506篇文章中,33篇文章被纳入本综述:19篇文章与静脉内激光消融有关,5篇文章与机械化学消融有关,7篇文章与射频消融有关,2篇文章同时与静脉内激光器消融和射频消融有关。静脉内激光消融、射频消融和机械化学消融的解剖成功率分别为94.3%、96.0%和88.1%,异质性均为中等。目前的大多数研究都是低质量的研究。因此,需要长期随访研究和大规模随机对照试验来获得高质量的证据。尽管治疗小隐静脉功能不全的金标准尚不明确,但静脉内消融术仍然是推荐的方法。
{"title":"A systematic review of endovenous ablation for the treatment of small saphenous varicose veins.","authors":"Junjie Tan, Yanhui Chen, Jianwen Huang, Weiguo Xu","doi":"10.1024/0301-1526/a001091","DOIUrl":"10.1024/0301-1526/a001091","url":null,"abstract":"<p><p><b></b> Insufficiency of the small saphenous vein causes 15% of varicose veins in the lower extremities. Endovenous ablation for the treatment of small saphenous vein varices has become a trend, and an increasing number of studies have reported the effects of different types of endovenous ablation in patients with small saphenous varicose veins. The purpose of this systematic review is to summarize the results of existing studies on endovenous ablation for the treatment of small saphenous varicose veins, compare its role and efficacy, and provide insights into the future development of endovenous ablation for treating small saphenous varicose veins. A systematic review of literature published from January 1, 2002 to January 1, 2022 was conducted from PubMed, Embase, and China Academic Journals full-text databases. The pre-determined inclusion criteria were clinical literature of endovenous ablation for treating small saphenous varicose veins. Keywords included \"ablation\", \"small saphenous vein\", \"lesser saphenous vein\", \"short saphenous vein\", \"xiaoyinjingmai\" and \"xiaorong\". Of the 506 articles screened, 33 articles were included in this review: 19 articles were related to endovenous laser ablation, five were related to mechanochemical ablation, seven were related to radiofrequency ablation, and two were related to both endovenous laser ablation and radiofrequency ablation. The anatomical success rate of endovenous laser ablation, radiofrequency ablation, and mechanochemical ablation were 94.3%, 96.0%, and 88.1%, respectively, and the heterogeneities were all moderate. Most of the current studies are of a low-quality level of research. Hence, long-term follow-up studies and large-scale randomized controlled trials are required to obtain high-quality evidence. Although the gold standard for the treatment of small saphenous vein insufficiency remains unclear, endovenous ablation is still the recommended method.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41151268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First experiences of ultrasound vector flow imaging at the femoropopliteal artery in peripheral arterial disease. 股腘动脉超声矢量流成像在外周动脉疾病中的首次经验。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-17 DOI: 10.1024/0301-1526/a001095
Tetyana Shchetynska-Marinova, Laurin Gerdes, Anna-Lena Hohneck, Laura Winter, Klaus Amendt, Kay Schwenke, Andreas L H Gerken, Yigang Du, Daniel Dürschmied, Martin Sigl

Background: The femoropopliteal artery (FPA) plays a central role in diagnosing and treating peripheral arterial disease (PAD). FPA lesions are the most frequent cause of intermittent claudication, and no other artery of the lower extremities is recanalised more frequently. Generally, ultrasound is the primary imaging tool in PAD, particularly FPA. With the development of high-frame-rate ultrasound technology in addition to traditional ultrasound modes, vector flow imaging (VFI) has provided deeper haemodynamic insights when used in the carotid artery. Here, we report the use of VFI at the FPA level in routine PAD examinations. Patients and methods: In this single-centre prospective study, we evaluated consecutive patients with PAD using B-mode imaging, colour Doppler, pulsed wave Doppler (PW) and vector flow. Hemodynamic parameters at predefined locations at the carotid artery and FPA were compared. Results: Qualitatively adequate VFI at all sites was possible in 76% of the patients with PAD. With decreasing volume flow from the common carotid artery to the internal carotid artery and from the common femoral artery via the superficial femoral artery to the popliteal artery, the correlation between VFI- and PW-derived-volume flow was high at every site. Based on different techniques, the VFI-derived values were significantly lower than the PW-derived values. The mean wall shear stress was significantly lower at all femoropopliteal sites than at the carotid sites, whereas the oscillatory shear index at the femoral site was higher than that at the carotid sites rather than at the popliteal location. Conclusions: Our findings suggest that vector flow data acquisition in the FPA is feasible in most patients with PAD. Therefore, with knowledge of the method and its limitations, VFI provides haemodynamic information beyond traditional ultrasound techniques and is a promising new tool for flow analysis in PAD.

背景:股腘动脉(FPA)在外周动脉疾病(PAD)的诊断和治疗中起着核心作用。FPA病变是间歇性跛行最常见的原因,没有其他下肢动脉再通的频率更高。一般来说,超声是PAD的主要成像工具,尤其是FPA。除了传统的超声模式外,随着高帧率超声技术的发展,矢量流成像(VFI)在颈动脉中使用时提供了更深入的血液动力学见解。在这里,我们报告了在常规PAD检查中使用FPA水平的VFI。患者和方法:在这项单中心前瞻性研究中,我们使用B模式成像、彩色多普勒、脉冲波多普勒(PW)和矢量流对连续的PAD患者进行了评估。比较颈动脉和FPA预定位置的血流动力学参数。结果:76%的PAD患者可以在所有部位进行定性的充分VFI。随着从颈总动脉到颈内动脉以及从股总动脉经股浅动脉到腘动脉的体积流量的减少,VFI和PW衍生的体积流量之间的相关性在每个部位都很高。基于不同的技术,VFI导出的值明显低于PW导出的值。股骨-腘窝所有部位的平均壁剪切应力均显著低于颈动脉部位,而股骨部位的振荡剪切指数高于颈动脉部位而非腘窝部位。结论:我们的研究结果表明,在大多数PAD患者中,FPA中的矢量流数据采集是可行的。因此,根据对该方法及其局限性的了解,VFI提供了传统超声技术之外的血液动力学信息,是PAD血流分析的一种有前途的新工具。
{"title":"First experiences of ultrasound vector flow imaging at the femoropopliteal artery in peripheral arterial disease.","authors":"Tetyana Shchetynska-Marinova, Laurin Gerdes, Anna-Lena Hohneck, Laura Winter, Klaus Amendt, Kay Schwenke, Andreas L H Gerken, Yigang Du, Daniel Dürschmied, Martin Sigl","doi":"10.1024/0301-1526/a001095","DOIUrl":"10.1024/0301-1526/a001095","url":null,"abstract":"<p><p><b></b> <i>Background:</i> The femoropopliteal artery (FPA) plays a central role in diagnosing and treating peripheral arterial disease (PAD). FPA lesions are the most frequent cause of intermittent claudication, and no other artery of the lower extremities is recanalised more frequently. Generally, ultrasound is the primary imaging tool in PAD, particularly FPA. With the development of high-frame-rate ultrasound technology in addition to traditional ultrasound modes, vector flow imaging (VFI) has provided deeper haemodynamic insights when used in the carotid artery. Here, we report the use of VFI at the FPA level in routine PAD examinations. <i>Patients and methods:</i> In this single-centre prospective study, we evaluated consecutive patients with PAD using B-mode imaging, colour Doppler, pulsed wave Doppler (PW) and vector flow. Hemodynamic parameters at predefined locations at the carotid artery and FPA were compared. <i>Results:</i> Qualitatively adequate VFI at all sites was possible in 76% of the patients with PAD. With decreasing volume flow from the common carotid artery to the internal carotid artery and from the common femoral artery via the superficial femoral artery to the popliteal artery, the correlation between VFI- and PW-derived-volume flow was high at every site. Based on different techniques, the VFI-derived values were significantly lower than the PW-derived values. The mean wall shear stress was significantly lower at all femoropopliteal sites than at the carotid sites, whereas the oscillatory shear index at the femoral site was higher than that at the carotid sites rather than at the popliteal location. <i>Conclusions:</i> Our findings suggest that vector flow data acquisition in the FPA is feasible in most patients with PAD. Therefore, with knowledge of the method and its limitations, VFI provides haemodynamic information beyond traditional ultrasound techniques and is a promising new tool for flow analysis in PAD.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of a balloon-expandable stent for symptomatic obstructions of the subclavian or innominate arteries. 球囊扩张支架治疗锁骨下动脉或无名动脉症状性阻塞的临床结果。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-03 DOI: 10.1024/0301-1526/a001092
Riccardo M Fumagalli, Kerstin Schürch, Alexandru Grigorean, Erik W Holy, Mario Münger, William Pleming, Nils Kucher, Stefano Barco

Background: Upper-extremity peripheral arterial disease (PAD) may present with a broad spectrum of signs and symptoms. If an endovascular treatment is planned, percutaneous angioplasty and stent placement may lead to a better patency compared to percutaneous angioplasty alone. We assessed the characteristics and clinical course of patients with upper-extremity PAD who received angioplasty and a balloon-expandable stent. Patients and methods: We analyzed data from consecutive patients treated with angioplasty and placement of a balloon-expandable BeSmooth Peripheral Stent System® (Bentley, Germany) at the Angiology Department (University Hospital Zurich) between 2018 and 2022. The primary outcome was re-intervention at the target lesion within 6 months from index angioplasty and during available follow-up. The study was approved by the local ethical commission. Results: A total of 27 patients were treated. The median age was 70 (Q1-Q3: 60-74) years and 59% were men. The subclavian artery (74%) represented the most frequently treated target lesion, followed by the innominate artery (26%). The mean improvement in blood pressure in the treated arm was 21 (95%CI 7 to 35) mmHg at 24 hours and 29 (95%CI 15 to 43) mmHg at 6 months. At 6 months, 2 (8%) patients required a target lesion re-intervention. During the remaining follow-up period up to 24 months, one of these two patients required additional intervention and a total of 3 (11%) patients died due to sepsis, cancer, and unknown causes, respectively. Conclusions: Percutaneous catheter-based treatment with a balloon-expandable stent for symptomatic upper extremity PAD appeared to be effective and safe.

背景:上肢外周动脉疾病(PAD)可能表现出广泛的体征和症状。如果计划进行血管内治疗,与单独的经皮血管成形术相比,经皮血管成型术和支架置入可能会带来更好的通畅性。我们评估了接受血管成形术和球囊扩张支架治疗的上肢PAD患者的特征和临床病程。患者和方法:我们分析了2018年至2022年间在血管科(苏黎世大学医院)接受血管成形术和放置球囊扩张BeSmooth外周支架系统®(德国本特利)的连续患者的数据。主要结果是在指数血管成形术后6个月内和随访期间对目标病变进行再次干预。这项研究得到了当地伦理委员会的批准。结果:共有27例患者接受了治疗。中位年龄为70岁(Q1-Q3:60-74),59%为男性。锁骨下动脉(74%)是最常治疗的靶病变,其次是无名动脉(26%)。治疗组24小时血压平均改善21(95%CI 7至35)mmHg,6个月血压平均改善29(95%CI 15至43)mmHg。6个月时,2名(8%)患者需要靶病变再干预。在长达24个月的剩余随访期内,这两名患者中有一名需要额外干预,共有3名(11%)患者分别死于败血症、癌症和未知原因。结论:经皮导管球囊扩张支架治疗症状性上肢PAD是有效和安全的。
{"title":"Clinical outcomes of a balloon-expandable stent for symptomatic obstructions of the subclavian or innominate arteries.","authors":"Riccardo M Fumagalli, Kerstin Schürch, Alexandru Grigorean, Erik W Holy, Mario Münger, William Pleming, Nils Kucher, Stefano Barco","doi":"10.1024/0301-1526/a001092","DOIUrl":"10.1024/0301-1526/a001092","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Upper-extremity peripheral arterial disease (PAD) may present with a broad spectrum of signs and symptoms. If an endovascular treatment is planned, percutaneous angioplasty and stent placement may lead to a better patency compared to percutaneous angioplasty alone. We assessed the characteristics and clinical course of patients with upper-extremity PAD who received angioplasty and a balloon-expandable stent. <i>Patients and methods:</i> We analyzed data from consecutive patients treated with angioplasty and placement of a balloon-expandable BeSmooth Peripheral Stent System<sup>®</sup> (Bentley, Germany) at the Angiology Department (University Hospital Zurich) between 2018 and 2022. The primary outcome was re-intervention at the target lesion within 6 months from index angioplasty and during available follow-up. The study was approved by the local ethical commission. <i>Results:</i> A total of 27 patients were treated. The median age was 70 (Q1-Q3: 60-74) years and 59% were men. The subclavian artery (74%) represented the most frequently treated target lesion, followed by the innominate artery (26%). The mean improvement in blood pressure in the treated arm was 21 (95%CI 7 to 35) mmHg at 24 hours and 29 (95%CI 15 to 43) mmHg at 6 months. At 6 months, 2 (8%) patients required a target lesion re-intervention. During the remaining follow-up period up to 24 months, one of these two patients required additional intervention and a total of 3 (11%) patients died due to sepsis, cancer, and unknown causes, respectively. <i>Conclusions:</i> Percutaneous catheter-based treatment with a balloon-expandable stent for symptomatic upper extremity PAD appeared to be effective and safe.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41154872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases. 在80岁及以上患有外周动脉疾病的患者中,指南推荐的治疗方法使用不足。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-23 DOI: 10.1024/0301-1526/a001094
Daniel Messiha, Olga Petrikhovich, Julia Lortz, David Pinsdorf, Kristina Hogrebe, Ramtin Knuschke, Ramona Hering, Mandy Schulz, Tienush Rassaf, Christos Rammos

Background: Ageing is a major cardiovascular risk factor with detrimental changes that culminate in a high atherosclerotic burden. Peripheral artery disease (PAD) is a major manifestation of atherosclerosis with high mortality. Guideline-recommended treatment is essential, however implementation is inadequate. With an ageing society, age-related inequalities are important and have not been elucidated in a high-risk PAD population on a nation-wide scale. We sought to analyse outpatient treatment structures and guideline adherence in treatment of PAD patients older than 80 years. Patients and methods: The study is based on ambulatory claims data comprising 70.1 million statutorily insured patients per year in Germany from 2009 to 2018. We analysed age-related differences in prevalence, pharmacotherapy and specialized outpatient care in PAD patients. Results: Of 17,633,970 PAD patients included, 28% were older than 80 years. PAD prevalence increased between 2008 and 2018 (1.85% vs. 3.14%), with the proportion of older patients increasing by a third (24.4% vs. 31.2%). Octogenarians were undertreated regarding guideline-recommended statin pharmacotherapy compared to younger patients while antiplatelets were prescribed more often (statins 2016: 46.5% vs. 52.4%; antiplatelets 2016 30.6% vs. 29.3%; p<.05). Furthermore, octogenarians received less specialized outpatient care (angiology: 6.4% vs. 9.5%, vascular surgery: 8.1% vs. 11.8%, cardiology: 25.2% vs. 29.2%, p<.05). Conclusions: Our results demonstrate that age-related differences in pharmacotherapy and specialized outpatient care of PAD patients are evident. While overall guideline-recommended outpatient treatment is low, patients 80 years and older are less likely to receive both, leaving age-related health inequalities a challenge of our future.

背景:衰老是一个主要的心血管风险因素,其有害变化最终导致高动脉粥样硬化负担。外周动脉疾病(PAD)是动脉粥样硬化的主要表现,死亡率高。指导方针建议的治疗是必不可少的,但实施不足。在老龄化社会中,与年龄相关的不平等现象很重要,尚未在全国范围内的高危PAD人群中得到阐明。我们试图分析80岁以上PAD患者的门诊治疗结构和指南依从性。患者和方法:该研究基于2009年至2018年德国每年7010万法定保险患者的动态索赔数据。我们分析了PAD患者在患病率、药物治疗和专科门诊护理方面与年龄相关的差异。结果:在17633970名PAD患者中,28%的患者年龄在80岁以上。PAD患病率在2008年至2018年间增加(1.85%对3.14%),老年患者的比例增加了三分之一(24.4%对31.2%)。与年轻患者相比,八旬老人在指南推荐的他汀类药物治疗方面治疗不足,而抗血小板药物的处方更频繁(他汀类药物2016年:46.5%对52.4%;抗血小板药物2016年30.6%对29.3%;结论:我们的研究结果表明,PAD患者在药物治疗和专科门诊护理方面与年龄相关的差异是明显的。虽然总体指南建议的门诊治疗较低,但80岁及以上的患者不太可能同时接受这两种治疗,这使得年龄相关的健康不平等成为我们的挑战将来
{"title":"Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases.","authors":"Daniel Messiha, Olga Petrikhovich, Julia Lortz, David Pinsdorf, Kristina Hogrebe, Ramtin Knuschke, Ramona Hering, Mandy Schulz, Tienush Rassaf, Christos Rammos","doi":"10.1024/0301-1526/a001094","DOIUrl":"10.1024/0301-1526/a001094","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Ageing is a major cardiovascular risk factor with detrimental changes that culminate in a high atherosclerotic burden. Peripheral artery disease (PAD) is a major manifestation of atherosclerosis with high mortality. Guideline-recommended treatment is essential, however implementation is inadequate. With an ageing society, age-related inequalities are important and have not been elucidated in a high-risk PAD population on a nation-wide scale. We sought to analyse outpatient treatment structures and guideline adherence in treatment of PAD patients older than 80 years. <i>Patients and methods:</i> The study is based on ambulatory claims data comprising 70.1 million statutorily insured patients per year in Germany from 2009 to 2018. We analysed age-related differences in prevalence, pharmacotherapy and specialized outpatient care in PAD patients. <i>Results:</i> Of 17,633,970 PAD patients included, 28% were older than 80 years. PAD prevalence increased between 2008 and 2018 (1.85% vs. 3.14%), with the proportion of older patients increasing by a third (24.4% vs. 31.2%). Octogenarians were undertreated regarding guideline-recommended statin pharmacotherapy compared to younger patients while antiplatelets were prescribed more often (statins 2016: 46.5% vs. 52.4%; antiplatelets 2016 30.6% vs. 29.3%; p<.05). Furthermore, octogenarians received less specialized outpatient care (angiology: 6.4% vs. 9.5%, vascular surgery: 8.1% vs. 11.8%, cardiology: 25.2% vs. 29.2%, p<.05). <i>Conclusions:</i> Our results demonstrate that age-related differences in pharmacotherapy and specialized outpatient care of PAD patients are evident. While overall guideline-recommended outpatient treatment is low, patients 80 years and older are less likely to receive both, leaving age-related health inequalities a challenge of our future.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49692631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intermittent negative pressure therapy in patients with no-option chronic limb-threatening ischemia. 间歇性负压治疗无选择的慢性肢体威胁性缺血患者。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-17 DOI: 10.1024/0301-1526/a001098
Shatlyk Yagshyyev, Phillip Hausmann, Yi Li, Julius Kempf, Katharina Zetzmann, Katia Dessi, Oxana Moosmann, Veronika Almasi-Sperling, Alexander Meyer, Andreas L H Gerken, Werner Lang, Ulrich Rother

Background: Aim of this study was to assess the influence of intermitted negative pressure (INP) therapy on the foot microcirculation in patients with no-option CLTI. Patients and methods: CLTI patients defined as no option for revascularization on the basis of an interdisciplinary vascular board decision (interventional radiology, vascular surgery) were included in this study. INP therapy was performed at home. Therapy regime was: 1 hour twice daily. Follow-up was after 6 weeks and 3 months. Microcirculation measurement was performed by laser Doppler flowmetry and white light spectrometry (oxygen to see, O2CTM). Following parameters were evaluated: oxygen saturation (sO2 in%), relative hemoglobin (rHb) and flow (in arbitrary units A.U.). Additionally the clinical outcome of the patients was assessed. Results: From September 2020 to June 2022, 228 patients were screened. In total 19 patients (13 men, 6 women, mean age was 73.95 years) were included. 6 weeks after INP therapy the microcirculation showed a significant improvement for the parameter sO2 (%) (p=0.004). After 3 months a non-significant decrease compared to 6 weeks follow-up was seen for the parameter sO2; however, the perfusion was still improved compared to baseline measurement. With regard to the microperfusion values flow (AU) and hemoglobin (AU), the changes were not significant. Clinically, the patients reported a significant reduction of rest pain after therapy (p=0.005). Conclusions: INP therapy in no-option CLTI patients showed a significant improvement of the skin perfusion after 6 weeks. Therefore, INP therapy might have therapeutic potential in these critical ill patients.

背景:本研究的目的是评估间歇负压(INP)治疗对无选择CLTI患者足部微循环的影响。患者和方法:根据跨学科血管委员会的决定(介入放射学、血管外科),CLTI患者被定义为无血运重建选择,纳入本研究。INP治疗在家中进行。治疗方案为:每天两次,每次1小时。随访6周3个月。通过激光多普勒流量计和白光光谱法(观察氧气,O2CTM)进行微循环测量。评估了以下参数:血氧饱和度(sO2,%)、相对血红蛋白(rHb)和流量(以A.U.为任意单位)。此外,还评估了患者的临床结果。结果:从2020年9月到2022年6月,共筛查了228名患者。共纳入19名患者(13名男性,6名女性,平均年龄73.95岁)。INP治疗6周后,微循环显示参数sO2(%)有显著改善(p=0.004)。3个月后,与6周随访相比,参数sO2无显著下降;然而,与基线测量相比,灌注仍然有所改善。微灌注值流量和血红蛋白的变化不显著。临床上,患者报告治疗后休息疼痛显著减轻(p=0.005)。结论:无选择CLTI患者的INP治疗在6周后显示皮肤灌注显著改善。因此,INP治疗可能对这些危重患者具有治疗潜力。
{"title":"Intermittent negative pressure therapy in patients with no-option chronic limb-threatening ischemia.","authors":"Shatlyk Yagshyyev, Phillip Hausmann, Yi Li, Julius Kempf, Katharina Zetzmann, Katia Dessi, Oxana Moosmann, Veronika Almasi-Sperling, Alexander Meyer, Andreas L H Gerken, Werner Lang, Ulrich Rother","doi":"10.1024/0301-1526/a001098","DOIUrl":"10.1024/0301-1526/a001098","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Aim of this study was to assess the influence of intermitted negative pressure (INP) therapy on the foot microcirculation in patients with no-option CLTI. <i>Patients and methods:</i> CLTI patients defined as no option for revascularization on the basis of an interdisciplinary vascular board decision (interventional radiology, vascular surgery) were included in this study. INP therapy was performed at home. Therapy regime was: 1 hour twice daily. Follow-up was after 6 weeks and 3 months. Microcirculation measurement was performed by laser Doppler flowmetry and white light spectrometry (oxygen to see, O2C<sup>TM</sup>). Following parameters were evaluated: oxygen saturation (sO2 in%), relative hemoglobin (rHb) and flow (in arbitrary units A.U.). Additionally the clinical outcome of the patients was assessed. <i>Results:</i> From September 2020 to June 2022, 228 patients were screened. In total 19 patients (13 men, 6 women, mean age was 73.95 years) were included. 6 weeks after INP therapy the microcirculation showed a significant improvement for the parameter sO2 (%) (p=0.004). After 3 months a non-significant decrease compared to 6 weeks follow-up was seen for the parameter sO2; however, the perfusion was still improved compared to baseline measurement. With regard to the microperfusion values flow (AU) and hemoglobin (AU), the changes were not significant. Clinically, the patients reported a significant reduction of rest pain after therapy (p=0.005). <i>Conclusions:</i> INP therapy in no-option CLTI patients showed a significant improvement of the skin perfusion after 6 weeks. Therefore, INP therapy might have therapeutic potential in these critical ill patients.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of endovascular therapy for peripheral arterial disease in all German hospitals. 德国所有医院外周动脉疾病的血管内治疗分析。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-06 DOI: 10.1024/0301-1526/a001093
Stefan Betge, Christiane Engelbertz, Christine Espinola-Klein, Wulf Ito, Christian Heiss, Britta Heilmeier, Ralf Langhoff, Nasser M Malyar

Background: The quality of vascular care has significantly improved in part by the expansion of endovascular techniques for the treatment of symptomatic peripheral artery disease (PAD) in recent years. In Germany these are primarily provided by the three disciplines of vascular surgery, angiology, and interventional radiology (IR). However, the relative contribute of angiologists to the total number of cases performed is unknown. Patients and methods: In the present study, we analysed the respective contribution of vascular surgery, angiology, and IR to the delivery of endovascular revascularisations in symptomatic PAD in Germany based on the legally mandatory quality reports representative for the reporting year 2018. Results: Vascular surgery is the most common speciality reporting procedures in German hospitals (n=579; 25.1%), followed by IR (n=264; 11.5%), angiology (n=189; 8.2%) and cardiology (n=17; 0.7%). The combination of vascular surgery and IR was reported in 202 (8.8%), vascular surgery and angiology in 167 (7.2%) and angiology and IR in 65 (2.8%) hospitals, and 63 (2.7%) hospitals reported the combination of all three disciplines. Not every department performed catheter interventions. The analysis of procedures per centre revealed that angiology centres provided the highest numbers for both basic procedures and more complex techniques such as atherectomy, rotational thrombectomy, lithoplasty, selective thrombolysis or the use of re-entry devices. In total, angiology centres provided 24.4% of the total procedures or 23.9% of the so-called basic procedures as a surrogate for patient numbers. Conclusions: While each of the disciplines contribute significantly to the endovascular procedures, angiology centres perform more procedures per centre and more complex procedures than the other disciplines highlighting the important quantitative and qualitative contribution of angiology specialists to the care of vascular patients. The inpatient catheter interventional care of patients with PAD is still too rarely carried out in a multi-disciplinary manner in Germany.

背景:近年来,血管内技术用于治疗症状性外周动脉疾病(PAD),在一定程度上提高了血管护理的质量。在德国,这些主要由血管外科、血管学和介入放射学(IR)三个学科提供。然而,血管科医生对病例总数的相对贡献尚不清楚。患者和方法:在本研究中,我们根据2018年报告年度的法定强制性质量报告代表,分析了血管外科、血管学和IR对德国症状性PAD血管内血运重建的各自贡献。结果:血管外科是德国医院最常见的专业报告程序(n=579;25.1%),其次是IR(n=264;11.5%)、血管学(n=189;8.2%)和心脏病学(n=17;0.7%)。202家(8.8%)报告了血管外科和IR的结合,167家(7.2%)报告血管外科和血管学,65家(2.8%)医院报告了血管学和IR,63家(2.7%)医院报告了三个学科的合并。并不是每个部门都进行了导管干预。对每个中心的手术分析显示,血管学中心为基本手术和更复杂的技术提供了最高的数量,如斑块切除术、血栓旋转切除术、取石术、选择性溶栓或使用重返装置。总的来说,血管病中心提供了24.4%的总手术或23.9%的所谓基本手术,作为患者人数的替代。结论:虽然每个学科都对血管内手术做出了重大贡献,但与其他学科相比,血管学中心每个中心执行的手术更多,程序更复杂,这突出了血管学专家对血管患者护理的重要定量和定性贡献。在德国,PAD患者的住院导管介入治疗仍然很少以多学科的方式进行。
{"title":"Analysis of endovascular therapy for peripheral arterial disease in all German hospitals.","authors":"Stefan Betge, Christiane Engelbertz, Christine Espinola-Klein, Wulf Ito, Christian Heiss, Britta Heilmeier, Ralf Langhoff, Nasser M Malyar","doi":"10.1024/0301-1526/a001093","DOIUrl":"10.1024/0301-1526/a001093","url":null,"abstract":"<p><p><b></b> <i>Background:</i> The quality of vascular care has significantly improved in part by the expansion of endovascular techniques for the treatment of symptomatic peripheral artery disease (PAD) in recent years. In Germany these are primarily provided by the three disciplines of vascular surgery, angiology, and interventional radiology (IR). However, the relative contribute of angiologists to the total number of cases performed is unknown. <i>Patients and methods:</i> In the present study, we analysed the respective contribution of vascular surgery, angiology, and IR to the delivery of endovascular revascularisations in symptomatic PAD in Germany based on the legally mandatory quality reports representative for the reporting year 2018. <i>Results:</i> Vascular surgery is the most common speciality reporting procedures in German hospitals (n=579; 25.1%), followed by IR (n=264; 11.5%), angiology (n=189; 8.2%) and cardiology (n=17; 0.7%). The combination of vascular surgery and IR was reported in 202 (8.8%), vascular surgery and angiology in 167 (7.2%) and angiology and IR in 65 (2.8%) hospitals, and 63 (2.7%) hospitals reported the combination of all three disciplines. Not every department performed catheter interventions. The analysis of procedures per centre revealed that angiology centres provided the highest numbers for both basic procedures and more complex techniques such as atherectomy, rotational thrombectomy, lithoplasty, selective thrombolysis or the use of re-entry devices. In total, angiology centres provided 24.4% of the total procedures or 23.9% of the so-called basic procedures as a surrogate for patient numbers. <i>Conclusions:</i> While each of the disciplines contribute significantly to the endovascular procedures, angiology centres perform more procedures per centre and more complex procedures than the other disciplines highlighting the important quantitative and qualitative contribution of angiology specialists to the care of vascular patients. The inpatient catheter interventional care of patients with PAD is still too rarely carried out in a multi-disciplinary manner in Germany.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41167366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vasa-european Journal of Vascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1